Is there a successful business case for telepharmacy?

Area of Science:

• Health Economics
• Pharmacy Management
• Business Analytics

Background:

• Assessing the financial viability of integrated pharmacy models is crucial for operational sustainability.
• Understanding the financial performance of a Single Business Unit (SBU) with multiple retail and telepharmacy locations is essential for strategic planning.

Purpose of the Study:

• To evaluate the financial operations of a Single Business Unit (SBU) comprising one central retail pharmacy and two remote telepharmacies.
• To analyze key financial metrics against industry benchmarks over a three-year period (2002-2004).

Main Methods:

• Conducted a financial analysis using income statements and balance sheets from 2002 to 2004.
• Compared SBU financial data, including gross profit and net operating income, to industry averages.
• Evaluated inventory turnover ratios in relation to pharmaceutical costs and obsolescence risks.

Main Results:

• Gross profit demonstrated a significant increase, rising from $260,093 in 2002 to $502,262 in 2004.
• Net operating income percentage improved from below industry average in prior years to above average in 2004.
• Inventory turnover ratio, while remaining below average, showed an upward trend, indicating improving efficiency.

Conclusions:

• The SBU exhibits a positive financial trend, approaching median sales benchmarks.
• Profitability in multi-location pharmacy settings is achievable with adequate patient volume and optimized pharmacist utilization.
• Continued monitoring of inventory turnover is recommended due to the financial implications of pharmaceutical obsolescence.